imipenem, anhydrous has been researched along with Febrile Neutropenia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, JY; Huang, HM; Huang, TH; Liu, HC; Lu, CH; Sun, FJ; Yeh, TC | 1 |
| Chen, X; Guo, S; Li, Y; Liang, X; Su, H; Tan, X; Xi, J | 1 |
| Jaruratanasirikul, S; Jullangkoon, M; Samaeng, M; Wongpoowarak, W | 1 |
| Emiroğlu, M; Köksal, Y; Köse, D | 1 |
| Huang, W; Jing, Y; Li, J; Wang, Q; Yu, L; Yuan, L; Zhao, X; Zhou, D | 1 |
1 review(s) available for imipenem, anhydrous and Febrile Neutropenia
| Article | Year |
|---|---|
Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia: A systematic review and Bayesian network meta-analysis.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Child; Drug Therapy, Combination; Febrile Neutropenia; Female; Humans; Imipenem; Male; Meropenem; Network Meta-Analysis; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
2 trial(s) available for imipenem, anhydrous and Febrile Neutropenia
| Article | Year |
|---|---|
Population pharmacokinetics and dosing simulations of imipenem in serious bacteraemia in immunocompromised patients with febrile neutropenia.
Topics: Acinetobacter; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Febrile Neutropenia; Female; Humans; Imipenem; Immunocompromised Host; Infusions, Intravenous; Klebsiella; Male; Middle Aged; Monte Carlo Method; Pseudomonas aeruginosa; Severity of Illness Index; Young Adult | 2015 |
Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.
Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Febrile Neutropenia; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis; Risk Factors | 2016 |
2 other study(ies) available for imipenem, anhydrous and Febrile Neutropenia
| Article | Year |
|---|---|
Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacteremia; Child; Ciprofloxacin; Febrile Neutropenia; Female; Humans; Imipenem; Leukemia, Myeloid, Acute; Male; Mycoses; Vancomycin; Voriconazole | 2021 |
High-risk febrile neutropenia and its management in children with solid tumors and lymphoma.
Topics: Amikacin; Anti-Bacterial Agents; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Child; Febrile Neutropenia; Female; Humans; Imipenem; Lymphoma; Male; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protein Precursors | 2015 |